Radiation Oncology

Papers
(The median citation count of Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent60
Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia60
A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma58
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial54
Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer54
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy52
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)50
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study43
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p43
Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer43
Correction to: 125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts41
Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery38
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis38
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov35
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy34
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prost33
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study33
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors33
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer33
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review30
Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis30
125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy30
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer30
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma29
Radiotherapy refusal in breast cancer with breast-conserving surgery29
Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET/CT images28
Evaluating differences in respiratory motion estimates during radiotherapy: a single planning 4DMRI versus daily 4DMRI27
A survey of cancer patients’ interest in undertaking exercise to promote relaxation during radiotherapy for breast cancer and metastatic cancer27
Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with27
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma26
Impact of radiation response on survival in pediatric medulloblastoma with residual or disseminated disease26
Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc th26
Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer26
Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma25
Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study24
Selectively recommend 18F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas24
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer23
Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers23
Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition?23
Correction to: High dose simultaneous integrated boost for node positive cervical cancer23
Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer23
Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis22
Preliminary study of feasibility of surface-guided radiotherapy with concurrent tumor treating fields for glioblastoma: region of interest22
Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas22
Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design21
Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis21
Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models20
Characteristics of locoregional extension of unilateral nasopharyngeal carcinoma and suggestions for clinical target volume delineation20
Online adaptive stereotactic body radiotherapy for localized prostate cancer in patients with lower urinary tract symptoms and/or prostate hyperplasia (X-SMILE)20
Carbon ion irradiation mobilizes antitumor immunity: from concept to the clinic20
Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer19
The roles of CC chemokines in response to radiation19
Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy19
Assessing intra- and interfraction motion and its dosimetric impacts on cervical cancer adaptive radiotherapy based on 1.5T MR-Linac18
A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients18
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease18
Review of cone beam computed tomography based online adaptive radiotherapy: current trend and future direction18
The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial18
Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer17
Radiation therapy for retroperitoneal sarcoma: practice patterns in North America17
Dosimetric effect of respiratory motion on planned dose in whole-breast volumetric modulated arc therapy using moderate and ultra-hypofractionation17
Outcomes of definitive radiotherapy vs. laryngectomy followed by adjuvant radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma: real-world experience in a referral cancer c17
Use of focal radiotherapy boost for prostate cancer: radiation oncologists’ perspectives and perceived barriers to implementation17
Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer17
Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: a prospective explorative study17
Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Syn17
Prostate radiotherapy may cause fertility issues: a retrospective analysis of testicular dose following modern radiotherapy techniques16
Clinical practice in stereotactic radiotherapy delivery at treatment unit: a practitioner survey and consensus-based recommendations for multidisciplinary professional development16
Deformable registration for nasopharyngeal carcinoma using adaptive mask and weight allocation strategy based CycleFCNs model16
Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation15
High buttocks supine position to reduce small bowel exposure in gynecological radiotherapy15
Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility study15
Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis15
Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas15
Influence and optimization strategy of the magnetic field in 1.5 T MR-linac liver stereotactic radiotherapy15
Evaluating the impact of possible interobserver variability in CBCT-based soft-tissue matching using TCP/NTCP models for prostate cancer radiotherapy15
Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older15
Deep learning-powered radiotherapy dose prediction: clinical insights from 622 patients across multiple sites tumor at a single institution14
Timing matters: diurnal spine length variation in pediatric patients during radiotherapy14
Predictors of osteoradionecrosis following irradiated tooth extraction14
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial14
Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy14
Improving total bone marrow and lymphoid irradiation: feasibility of intensity-modulated proton therapy (IMPT) and dosimetric comparison with helical tomotherapy (HT)14
Prognostic value of tumour-stroma ratio in nasopharyngeal carcinoma: a two-center retrospective study14
Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions – dosimetric impact and how to detect its extent in advance14
The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy13
Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study13
Efficacy and safety of induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced non-small cell lung cancer: A retrospective study13
Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach13
Dosimetric evaluation of VMAT and helical tomotherapy techniques comparing conventional volumes with clinical target volumes based on new ESTRO ACROP post-mastectomy with immediate implant reconstruct13
Identification of variables and development of a prediction model for DIBH eligibility in left-sided breast cancer radiotherapy: a prospective cohort study with temporal validation13
A PET/CT radiomics model for predicting distant metastasis in early-stage non–small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study13
Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity13
Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer13
The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis12
Generation of tissues outside the field of view (FOV) of radiation therapy simulation imaging based on machine learning and patient body outline (PBO)12
Application of four-dimensional cone beam computed tomography in lung cancer radiotherapy12
Dosimetric evaluation of LINAC-based single-isocenter multi-target multi-fraction stereotactic radiosurgery with more than 20 targets: comparing MME, HyperArc, and RapidArc12
Chemoradiation for oesophageal cancer: the choice of treatment modality12
Dose prediction for cervical cancer VMAT patients with a full-scale 3D-cGAN-based model and the comparison of different input data on the prediction results12
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradia12
The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study12
Automatic IMRT treatment planning through fluence prediction and plan fine-tuning for nasopharyngeal carcinoma12
Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study12
High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region11
Pneumonitis after normofractionated radioimmunotherapy: a method for dosimetric evaluation11
Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy11
Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy11
Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers11
Therapeutic and prognostic impact of target volume delineation in postoperative radiotherapy for high-grade glioma patients with subventricular zone involvement11
Localized fine-tuning and clinical evaluation of deep-learning based auto-segmentation (DLAS) model for clinical target volume (CTV) and organs-at-risk (OAR) in rectal cancer radiotherapy11
Deep learning tools for the cancer clinic: an open-source framework with head and neck contour validation11
Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database10
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal envir10
Research trends and hot spots in the prevention and management of radiation dermatitis: a bibliometric analysis based on CiteSpace10
Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features10
Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis10
Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis10
Impact of random outliers in auto-segmented targets on radiotherapy treatment plans for glioblastoma10
DeepBeam: a machine learning framework for tuning the primary electron beam of the PRIMO Monte Carlo software10
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial10
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs10
Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy10
Generation of ozone during irradiation using medical linear accelerators: an experimental study10
Interfractional variation in whole-breast VMAT irradiation: a dosimetric study with complementary SGRT and CBCT patient setup10
Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer10
MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience10
Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy10
FAPI-PET/CT guided radiotherapy for patients with esophageal cancer10
Single-cell transcriptional analysis of irradiated skin reveals changes in fibroblast subpopulations and variability in caveolin expression10
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis10
Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.10
Radiation-induced senescence: therapeutic opportunities10
Radiologic criteria of retropharyngeal lymph node metastasis in maxillary sinus cancer10
Cardiac substructure dose distributions in node-positive and node-negative breast cancer patients undergoing 3D-CRT: comparing the predictive accuracy of mean heart dose and mean left ventricular dose10
The role of deep hyperthermia in IMRT in elderly patients with esophageal cancer: a retrospective cohort study10
Correction: Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer10
A deep learning-based dose calculation method for volumetric modulated arc therapy10
HLA-DQA1 expression is associated with prognosis and predictable with radiomics in breast cancer10
A novel knowledge-based prediction model for estimating an initial equivalent uniform dose in semi-auto-planning for cervical cancer10
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer10
Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer10
BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma9
The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer9
End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma9
Heart atlas for retrospective cardiac dosimetry: a multi-institutional study on interobserver contouring variations and their dosimetric impact9
Bone matching versus tumor matching in image-guided carbon ion radiotherapy for locally advanced non-small cell lung cancer9
Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma9
Early-onset adverse events after stereotactic radiosurgery for jugular foramen schwannoma: a mid-term follow-up single-center review of 46 cases9
Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study9
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer9
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial9
Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy9
Risk factors for severity of breast cancer-related lymphedema9
High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapy9
Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review9
Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy9
Development of delayed pulmonary toxicities and transcriptional changes in pre-existing interstitial lung disease mice after partial thoracic irradiation9
Practical recommendations for the management of radiodermatitis: on behalf of the ESTRO RTT committee9
Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study9
Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small-cell lung cancer: the PUMA trial9
Analytical setup margin for spinal stereotactic body radiotherapy based on measured errors9
Assessing organ at risk position variation and its impact on delivered dose in kidney SABR9
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial9
Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase9
Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer9
Regularity and correlation analysis of regional lymph node metastasis in nonoperative patients with non-small cell lung cancer based on positron emission tomography/computed tomography images8
Prognostic value of neutrophil to lymphocyte ratio and lymphocyte counts before durvalumab consolidation after radio-chemotherapy in locally advanced non-small cell lung cancer8
Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis8
Synthetic CT generation from CBCT and MRI using StarGAN in the Pelvic Region8
Monte Carlo simulation of linac using PRIMO8
Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine8
Clinical application of MR-Linac in tumor radiotherapy: a systematic review8
Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems8
Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities8
A focused review of statistical practices for relating radiation dose-volume exposure and toxicity8
Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes8
A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma8
Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study8
Measuring out-of-field dose to the hippocampus in common radiotherapy indications8
Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study8
Prognostic nomogram for synchronous metastatic nasopharyngeal carcinoma: a retrospective multicentre study8
Developing an automatic treatment record review system for quality assurance of patient treatment delivery in radiation therapy8
Palliative radiotherapy for painful lymph node metastases8
Evaluating ECM stiffness and liver cancer radiation response via shear-wave elasticity in 3D culture models8
Outcomes of carbon ion radiotherapy compared with segmentectomy for ground glass opacity-dominant early-stage lung cancer8
Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer8
Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges8
Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer8
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma8
Predicting the survival of patients with painful tumours treated with palliative radiotherapy: a secondary analysis using the 3-variable number-of-risk-factors model8
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma8
Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)8
PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer8
Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre8
Prognostic implications of tumor volume reduction during radiotherapy in locally advanced cervical cancer: a risk-stratified analysis8
Towards deep-learning (DL) based fully automated target delineation for rectal cancer neoadjuvant radiotherapy using a divide-and-conquer strategy: a study with multicenter blind and randomized valida8
Correction: Evolution of radiation-induced temporal lobe injury after intensity-modulated radiation therapy in nasopharyngeal carcinoma: a large cohort retrospective study8
Gastric side effects and the stomach dosimetric analysis in left-sided breast cancer radiotherapy in free-breathing and deep inspiration breath-hold technique8
Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma8
A review of diffusion-weighted magnetic resonance imaging in head and neck cancer patients for treatment evaluation and prediction of radiation-induced xerostomia8
Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter,8
A nomogram based on circulating CD8+ T cell and platelet-to-lymphocyte ratio to predict overall survival of patients with locally advanced nasopharyngeal carcinoma8
Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer8
Advancements of radiotherapy for recurrent head and neck cancer in modern era8
ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma8
Deep learning for segmentation of the cervical cancer gross tumor volume on magnetic resonance imaging for brachytherapy8
Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia8
Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence7
Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology7
A cycle generative adversarial network for improving the quality of four-dimensional cone-beam computed tomography images7
PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma7
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort7
Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study7
Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction7
Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up7
Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses7
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review7
Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis7
Minimizing human interference in an online fully automated daily adaptive radiotherapy workflow for bladder cancer7
Simultaneous dose distribution and fluence prediction for nasopharyngeal carcinoma IMRT7
Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study7
Risk stratification of node-positive early-stage cervical cancer treated with radical hysterectomy followed by chemoradiotherapy: a retrospective single-center study7
Radiotherapy outcomes and risk factors for young patients with head-and-neck squamous cell carcinomas: a matched-pair analysis7
Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis7
High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer7
Impact of interplay effects on spot scanning proton therapy with motion mitigation techniques for lung cancer: SFUD versus robustly optimized IMPT plans utilizing a four-dimensional dynamic dose simul7
Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort7
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)7
Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors7
Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer7
Neck muscle training improving the setup of reproducibility in patient with head and neck cancer receiving radiotherapy - a prospective randomized controlled study7
Effectiveness of bladder filling control during online MR-guided adaptive radiotherapy for rectal cancer7
Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit7
Treatment results for patients with squamous-cell carcinoma of the anus, a single institution retrospective analysis7
Quantifying the reduction of respiratory motion by mechanical ventilation with MRI for radiotherapy7
A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy7
Dosimetry study of three-dimensional print template for 125I implantation therapy7
Functional brain imaging interventions for radiation therapy planning in patients with glioblastoma: a systematic review7
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer7
The investigation of opening modes of head and neck thermoplastic mask for radiotherapy based on finite element analysis7
Rectal retractor in prostate radiotherapy: pros and cons7
Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients7
Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study7
Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins7
Postoperative radiotherapy for supraglottic cancer on real-world data: can we reduce dose to lymph node levels?7
Protocol of a phase II study to evaluate the efficacy and safety of deep-inspiration breath-hold daily online adaptive radiotherapy for centrally located lung tumours (PUDDING study)7
A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy7
IMPT of head and neck cancer: unsupervised machine learning treatment planning strategy for reducing radiation dermatitis7
Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases7
0.17640495300293